ORIC-101
ORIC-101-02
Phase 1 small_molecule terminated
Quick answer
ORIC-101 for Prostatic Neoplasms is a Phase 1 program (small_molecule) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oric Pharmaceuticals
- Indication
- Prostatic Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated